Literature DB >> 23537830

Preparation of Eudragit L 100-55 enteric nanoparticles by a novel emulsion diffusion method.

Shilei Hao1, Bochu Wang, Yazhou Wang, Liancai Zhu, Bin Wang, Tingwang Guo.   

Abstract

In this study, a novel emulsion diffusion method was used to prepare enteric Eudragit L100-55 nanoparticles by ultrasonic dispersion and diffusion solidification. Omeprazole was selected as the model drug. The prepared nanoparticles were in spherical shape and exhibited negative zeta potential. The Fourier transform infrared spectroscopy results indicated that no molecular interaction occurred between the drug molecule and polymer chain. In addition, the nanoparticles showed a strong pH-sensitive release in vitro. A mild cytotoxicity of nanoparticle was observed in the subsequent studies, and the particle cellular uptake study showed that the nanoparticles could be taken up by Caco-2 cells after 0.5h incubation. Our results indicated that the enteric Eudragit L 100-55 nanoparticle could be synthesized successfully via this ultrasonic solidification method, which also could be applied to prepare other pH-sensitive polymer nanoparticles.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537830     DOI: 10.1016/j.colsurfb.2013.02.036

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  10 in total

1.  Preparation and characterization of Eudragit L 100-55/chitosan enteric nanoparticles containing omeprazole using general factorial design: in vitro/in vivo study.

Authors:  Mahboubeh Rezazadeh; Reza Safaran; Mohsen Minaiyan; Abolfazl Mostafavi
Journal:  Res Pharm Sci       Date:  2021-06-30

2.  Development of keratin nanoparticles for controlled gastric mucoadhesion and drug release.

Authors:  Zhongjun Cheng; Xiaoliang Chen; Dongliang Zhai; Feiyan Gao; Tingwang Guo; Wenfeng Li; Shilei Hao; Jingou Ji; Bochu Wang
Journal:  J Nanobiotechnology       Date:  2018-03-19       Impact factor: 10.435

3.  Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.

Authors:  Tochukwu C Okwuosa; Beatriz C Pereira; Basel Arafat; Milena Cieszynska; Abdullah Isreb; Mohamed A Alhnan
Journal:  Pharm Res       Date:  2016-12-09       Impact factor: 4.200

4.  Electrosprayed microparticles for intestinal delivery of prednisolone.

Authors:  T Shams; U E Illangakoon; M Parhizkar; A H Harker; S Edirisinghe; M Orlu; M Edirisinghe
Journal:  J R Soc Interface       Date:  2018-08       Impact factor: 4.118

5.  Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers.

Authors:  Pataranapa Nimtrakul; Pakawadee Sermsappasuk; Waree Tiyaboonchai
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 6.  Additive Manufacturing of Oral Tablets: Technologies, Materials and Printed Tablets.

Authors:  Alperen Abaci; Christina Gedeon; Anna Kuna; Murat Guvendiren
Journal:  Pharmaceutics       Date:  2021-01-25       Impact factor: 6.321

Review 7.  Exploring Various Techniques for the Chemical and Biological Synthesis of Polymeric Nanoparticles.

Authors:  Thiruchelvi Pulingam; Parisa Foroozandeh; Jo-Ann Chuah; Kumar Sudesh
Journal:  Nanomaterials (Basel)       Date:  2022-02-08       Impact factor: 5.076

Review 8.  Pharmaceutical Coating and Its Different Approaches, a Review.

Authors:  Ahmad Salawi
Journal:  Polymers (Basel)       Date:  2022-08-15       Impact factor: 4.967

9.  Eudragit® L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation.

Authors:  Shahla Mirzaeei; Shiva Taghe; Raid G Alany; Ali Nokhodchi
Journal:  Biomedicines       Date:  2022-08-08

Review 10.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.